REZENOPY™ received approval from the U.S. Food and Drug Administration (the "FDA”) on April 19, 2024. The newly issued patent is eligible for listing in the FDA’s Orange Book and, if listed, may ...
Five structural shifts redefining strategy, leadership, and performance—and what leaders must master to compete and grow in a ...
Goliath has acquired Crazy Aaron’s, expanding its global footprint in toys and sensory play while building on an existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback